Press release
Software as a Medical Device (SaMD) Market to Reach USD 17.54 Billion by 2034 Fueled by AI-Driven Diagnostics & Digital Therapeutics
Software as a Medical Device (SaMD) Market
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73682
Market Summary
The SaMD Market is expanding quickly as healthcare providers, medtech companies, and regulators embrace software-driven clinical decision-making, diagnostics, and treatment delivery. SaMD solutions operate independently of hardware medical devices and are widely used for AI-powered radiology interpretation, cardiology analysis, diabetes management, mental health therapy, remote patient monitoring, oncology decision-support, and personalized digital therapeutics.
Rising prevalence of chronic diseases, growing telemedicine adoption, and increasing regulatory clarity from the FDA, EU MDR, and IMDRF are accelerating global market adoption. North America leads the market due to strong digital health integration, while Asia-Pacific is the fastest-growing region driven by healthcare digitalization and smartphone penetration.
Key Takeaways
• 2024 Market Size: USD 5.98 Billion
• 2034 Forecast: USD 17.54 Billion
• CAGR: 11.4% (2025-2034)
• Strong growth in AI-based diagnostics & clinical decision support
• Digital therapeutics gaining regulatory approvals worldwide
• Asia-Pacific showing highest adoption growth in remote monitoring & mobile-health SaMD
Market Drivers
• Increased demand for software-based diagnostics & digital care delivery
• Strong regulatory support for SaMD frameworks across major regions
• Rapid growth of AI, machine learning & cloud-based healthcare analytics
• Expansion of digital therapeutics for chronic diseases & mental health
• Rising use of SaMD in imaging, cardiology, oncology & remote monitoring
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73682/software-as-a-medical-device-market
Segmentation Snapshot
By Device Type
• AI-Based Diagnostic Software
• Monitoring & Management Software
• Digital Therapeutics (DTx)
• Clinical Decision Support Software
• Others
By Application
• Cardiology
• Diabetes & Metabolic Disorders
• Radiology & Imaging
• Mental Health
• Oncology
• Neurology
• Others
By Deployment Mode
• Cloud-Based
• On-Premise
By End User
• Hospitals
• Clinics
• Diagnostic Centers
• Home Users / Patients
• Research Organizations
By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73682
Recent Developments
• FDA approvals for new AI-powered SaMD platforms in radiology and cardiology.
• Expansion of digital therapeutics for mental health, addiction & chronic disease management.
• Rising collaborations between tech companies and medtech manufacturers for algorithm development.
• Cloud-native SaMD solutions gaining adoption for multi-site data integration.
Expert Quote - Irfan Tamboli, Business Development Executive
"Software as a Medical Device is reshaping modern healthcare by merging clinical intelligence with digital innovation. AI-driven SaMD solutions are empowering faster diagnosis, continuous monitoring, and personalized therapeutic interventions."
Conclusion
The SaMD Market will experience strong momentum through 2034 as AI, cloud computing, digital therapeutics, and remote patient monitoring accelerate global healthcare digitalization. Companies offering regulatory-compliant, interoperable, and clinically validated SaMD platforms will lead the next era of medical innovation.
This report is also available in the following languages : Japanese (医療機器市場としてのソフトウェア), Korean (의료기기 시장으로서의 소프트웨어), Chinese (软件即医疗器械市场), French (Marché des logiciels en tant que dispositifs médicaux), German (Software als Medizinproduktmarkt), and Italian (Mercato del software come dispositivo medico), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73682
Our More Reports:
Partial Epilepsy Market
https://exactitudeconsultancy.com/reports/72067/partial-epilepsy-market
Partial Seizure Market
https://exactitudeconsultancy.com/reports/72069/partial-seizure-market
Primary Progressive Multiple Sclerosis (PPMS) Market
https://exactitudeconsultancy.com/reports/72071/primary-progressive-multiple-sclerosis-ppms-market
Small Fiber Neuropathy Market
https://exactitudeconsultancy.com/reports/72073/small-fiber-neuropathy-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Software as a Medical Device (SaMD) Market to Reach USD 17.54 Billion by 2034 Fueled by AI-Driven Diagnostics & Digital Therapeutics here
News-ID: 4303088 • Views: …
More Releases from Exactitude Consultancy
Breath Analyzers Market to Reach USD 3.42 Billion by 2034
Pune, India - December 2025 - The global Breath Analyzers Market, valued at USD 1.82 billion in 2024, is projected to reach USD 3.42 billion by 2034, growing at a 6.4% CAGR (2025-2034), according to Exactitude Consultancy. Increasing adoption of alcohol breath testing devices, expanding drug-abuse screening programs, and rising use of breath analysis in medical diagnostics are steering strong market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73199
Market…
DNA Test Kits Market to Reach USD 4.86 Billion by 2034 Driven by Rise in Ancestr …
Pune, India - December 2025 - The global DNA Test Kits Market, valued at USD 1.98 billion in 2024, is projected to reach USD 4.86 billion by 2034, expanding at a strong 9.4% CAGR (2025-2034), according to Exactitude Consultancy. Increasing adoption of direct-to-consumer (DTC) genetic testing, personalized wellness programs, and advances in genomics are fueling the market's rapid expansion.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73195
Market Summary
The DNA Test…
Spinal Cord Injury (SCI) - Epidemiology Forecast & Market Outlook to 2034
Disease Background & Classification
Spinal Cord Injury (SCI) is a neurological condition caused by traumatic or non-traumatic damage to the spinal cord, resulting in varying degrees of motor, sensory, and autonomic dysfunction.
Types of SCI
• Traumatic SCI: Road accidents, falls, sports injuries, violence
• Non-traumatic SCI: Tumors, infections, degenerative spine disorders, ischemia
Functional Classification
• Tetraplegia (cervical injury)
• Paraplegia (thoracic/lumbar injury)
• Complete vs. incomplete injuries based on ASIA scale
Global Epidemiology Overview (2024)
Based on consolidated multi-regional data (WHO-based models, trauma registries,…
Global Vagus Nerve Stimulator (VNS) Market Accelerates as Neuromodulation Expand …
Market Definition
The Vagus Nerve Stimulator (VNS) Market includes implantable and non-invasive devices that deliver electrical impulses to the vagus nerve to modulate neurological, psychiatric, and autonomic pathways.
1. Implantable VNS Systems (Largest Market Segment)
Widely used for:
• Drug-resistant epilepsy
• Treatment-resistant depression (in select regions)
Core components:
• Implanted pulse generator
• Lead wires wrapped around the vagus nerve
• External programming and monitoring system
2. Non-Invasive VNS (nVNS) Devices (Fastest-Growing Segment)
Transcutaneous stimulators placed on the neck or ear.
Applications include:
• Migraine and cluster headache
• Anxiety…
More Releases for SaMD
U.S Software as a Medical Device (SaMD) Market Growth & Trends 2025
The US Software as a Medical Device Market reached US$ 205.12 million in 2024 and is expected to reach US$ 715.00 million by 2033, growing at a CAGR of 13.5% during the forecast period 2025-2033.
U.S Software As A Medical Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to…
Software as a Medical Device Market (SaMD): A Game-Changer in Modern Healthcare
Software as a medical devices (SaMD) market is estimated to reach at a CAGR of 69.31% during the forecast period (2024-2031).
Software as a Medical Device (SaMD) refers to standalone software intended for medical purposes without being part of a physical medical device. SaMD can perform tasks such as diagnosing conditions, predicting treatment outcomes, or monitoring chronic diseases. Examples include mobile apps for tracking heart health, AI-driven diagnostic tools, and cloud-based…
Key Influencer in the Software As A Medical Device (SaMD) Market 2025: IOT Revol …
What combination of drivers is leading to accelerated growth in the software as a medical device (samd) market?
The increasing use of the Internet of Things (IoT) within the healthcare industry is likely to fuel the expansion of the software as a medical device (SaMD) market in the future. IoT in healthcare refers to medical equipment and software which can interact with digital networks to gain access to healthcare IT systems.…
Software as a Medical Device (SaMD) Market Size, Share, Trends, and Forecast 202 …
"The Business Research Company recently released a comprehensive report on the Global (SaMD) Software As A Medical Device Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get…
Hottest Trends in 2023 Software as a Medical Device (SaMD) Market| Inzentiz, Jab …
2023-2031 Report on Global Software as a Medical Device (SaMD) Market by Player, Region, Type, Application and Sales Channel is the latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities, and leveraging strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Software as a Medical Device (SaMD) Market.…
Software as a Medical Device (SaMD) Market 2021 | Detailed Report
The Software as a Medical Device (SaMD) research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information…
